Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Oxford Gene Technology (OGT) is a molecular genetics company that provides innovative clinical genetics and diagnostic solutions. Founded by Sir Edwin Southern, the inventor of the Southern blot, the company specializes in high-quality FISH probes, NGS panels, and microarray products under the CytoCell, SureSeq, and CytoSure brands. OGT's products and services are primarily used in oncology and reproductive health for the detection of genetic abnormalities. In 2017, OGT was acquired by Sysmex Corporation, integrating its genomic expertise into Sysmex's global diagnostic portfolio. The company continues to operate as a key part of Sysmex's Life Science business, focusing on the development of advanced genomic tools for personalized medicine.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on OGT Services.